Literature DB >> 33635775

Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report.

Andrew S Fang1, Lee Jae Morse2, Rosanna Wustrack3, Ryan Huber4, Minggui Pan5.   

Abstract

CASE
PRESENTATION: A 33-year old man presented with a 25-cm lower extremity embryonal rhabdomyosarcoma with presumed extensive nodal metastasis on positron emission topography scan. Neoadjuvant chemotherapy and radiation provided minimal response. Following limb salvage resection and flap coverage, a prolonged postoperative infection occurred requiring intravenous antibiotics and wound care over 5 months. Given the infection, no postoperative radiation or chemotherapy was administered. Eight months following surgery, positron emission topography scan showed complete regression of local and nodal disease. The patient has remained in complete remission for more than 4 years.
CONCLUSION: Postoperative wound infection leading to complete regression of embryonal rhabdomyosarcoma has not been reported. Stimulation of the innate and adaptive immune system through infectious elements is an area of ongoing immunotherapy research to improve sarcoma treatment outcomes.
Copyright © 2020 The Permanente Press. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33635775      PMCID: PMC8817904          DOI: 10.7812/TPP/20.172

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  27 in total

1.  II. Contribution to the Knowledge of Sarcoma.

Authors:  W B Coley
Journal:  Ann Surg       Date:  1891-09       Impact factor: 12.969

2.  Childhood infectious diseases and risk of leukaemia in an adult population.

Authors:  Bernd Krone; Klaus F Kölmel; John M Grange
Journal:  Int J Cancer       Date:  2013-08-01       Impact factor: 7.396

3.  Does postoperative infection after soft tissue sarcoma resection affect oncologic outcomes?

Authors:  Nicole K Behnke; Vignesh K Alamanda; Yanna Song; Kristin R Archer; Jennifer L Halpern; Herbert S Schwartz; Ginger E Holt
Journal:  J Surg Oncol       Date:  2013-11-28       Impact factor: 3.454

4.  Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.

Authors:  Travis B Kidner; Donald L Morton; Delphine J Lee; Mary Hoban; Leland J Foshag; Roderick R Turner; Mark B Faries
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

5.  Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study.

Authors:  B Krone; K F Kölmel; J M Grange; G Mastrangelo; B M Henz; I N Botev; M Niin; C Seebacher; D Lambert; R Shafir; E-M Kokoschka; U R Kleeberg; O Gefeller; A Pfahlberg
Journal:  Eur J Cancer       Date:  2003-11       Impact factor: 9.162

6.  Review of mifamurtide in the treatment of patients with osteosarcoma.

Authors:  Leo Kager; Ulrike Pötschger; Stefan Bielack
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

7.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

8.  Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

Authors:  Alexander J Chou; Eugenie S Kleinerman; Mark D Krailo; Zhengjia Chen; Donna L Betcher; John H Healey; Ernest U Conrad; Michael L Nieder; Michael A Weiner; Robert J Wells; Richard B Womer; Paul A Meyers
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

9.  Childhood infectious diseases and risk of leukaemia in an adult population.

Authors:  Stefano Parodi; Paolo Crosignani; Lucia Miligi; Oriana Nanni; Valerio Ramazzotti; Stefania Rodella; Adele Seniori Costantini; Rosario Tumino; Carla Vindigni; Paolo Vineis; Emanuele Stagnaro
Journal:  Int J Cancer       Date:  2013-07-06       Impact factor: 7.396

Review 10.  Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer.

Authors:  Tiffany Seto; Danny Sam; Minggui Pan
Journal:  Med Sci (Basel)       Date:  2019-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.